Aug. 7 at 1:17 PM
$FITY Strategic Core & Focus AreasFifty 1 Labs announced a strategic shift to position itself as a peptide biotechnology and telehealth company. The strategy focuses primarily on:Musculoskeletal (MSK) Health & Recovery: Targeting tissue healing, injury rehabilitation, post-surgical recovery, and sports performance.Target Compounds: Planning research and commercial pathways around known investigational peptides such as BPC-157, TB-500, MOTS-c, and Sermorelin, alongside novel peptide analogues.AI Integration: Utilizing AI-assisted discovery workflows (in silico candidate generation, pathway mapping) to streamline candidate selection and formulation development.